FDA’s inspection woes to grow if agency doesn’t address COVID-19 backlog: GAO
The Government Accountability Office has concerns about the FDA’s widening inspection backlog. COVID-19 certainly amplified the problem, but the issues had been mounting long before last March. As the FDA looks to honor lockdown rules and protect its staffers, the agency has largely paused inspections since the pandemic started last spring, conducting only those deemed “mission critical.”… Read More »
